• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体活性趋化因子受体在外泌体上表达。

Ligand-competent fractalkine receptor is expressed on exosomes.

作者信息

Park Eun Jeong, Myint Phyoe Kyawe, Appiah Michael G, Worawattananutai Patsorn, Inprasit Janjira, Prajuabjinda Onmanee, Soe Zay Yar, Gaowa Arong, Kawamoto Eiji, Shimaoka Motomu

机构信息

Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.

Department of Emergency and Disaster Medicine, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.

出版信息

Biochem Biophys Rep. 2021 Feb 2;26:100932. doi: 10.1016/j.bbrep.2021.100932. eCollection 2021 Jul.

DOI:10.1016/j.bbrep.2021.100932
PMID:33553692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7859287/
Abstract

Expression of chemokine receptor CX3CR1 is reportedly restricted to several cell types including natural killer cells, cytotoxic T cells, monocytes, and macrophages. However, its expression and function on exosomes, which are nanosized extracellular vesicles known to act as mediators of intercellular communications, remain unclear. Here, we investigated CX3CR1 expression on exosomes isolated from various cell types. Although we found that all the exosomes tested in our study highly expressed CX3CR1, this chemokine receptor was expressed only inside, but barely on, their source cells. Moreover, exosomal CX3CR1 was capable of binding soluble CX3CL1. Therefore, our study suggests that CX3CR1 is a novel and ligand-competent exosome receptor.

摘要

据报道,趋化因子受体CX3CR1的表达仅限于几种细胞类型,包括自然杀伤细胞、细胞毒性T细胞、单核细胞和巨噬细胞。然而,其在作为细胞间通讯介质的纳米级细胞外囊泡——外泌体上的表达和功能仍不清楚。在此,我们研究了从各种细胞类型中分离出的外泌体上CX3CR1的表达情况。尽管我们发现本研究中测试的所有外泌体都高度表达CX3CR1,但这种趋化因子受体仅在其来源细胞内部表达,而在细胞表面几乎不表达。此外,外泌体CX3CR1能够结合可溶性CX3CL1。因此,我们的研究表明CX3CR1是一种新型的、具有配体结合能力的外泌体受体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/e31f44727500/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/968a9b8d7617/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/fa962119182c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/921a4bccf3fe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/67f4b323b54f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/7def9b548ede/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/e31f44727500/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/968a9b8d7617/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/fa962119182c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/921a4bccf3fe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/67f4b323b54f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/7def9b548ede/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b07/7859287/e31f44727500/gr5.jpg

相似文献

1
Ligand-competent fractalkine receptor is expressed on exosomes.配体活性趋化因子受体在外泌体上表达。
Biochem Biophys Rep. 2021 Feb 2;26:100932. doi: 10.1016/j.bbrep.2021.100932. eCollection 2021 Jul.
2
Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.循环 fractalkine(CX3CL1)和 CX3CR1(+)CD4(+)T 细胞与慢性肾脏病患者颈总动脉内膜中层厚度的关系。
J Atheroscler Thromb. 2011;18(11):958-65. doi: 10.5551/jat.8722. Epub 2011 Aug 27.
3
Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.嗜酸性粒细胞趋化因子 3/CC 趋化因子配体 26 是 CX3CR1 的功能配体。
J Immunol. 2010 Dec 1;185(11):6472-9. doi: 10.4049/jimmunol.0904126. Epub 2010 Oct 25.
4
The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.CC趋化因子MCP-1通过p38丝裂原活化蛋白激酶刺激CX3CR1的表面表达,并增强单核细胞与fractalkine/CX3CL1的黏附。
J Immunol. 2006 Jun 15;176(12):7412-20. doi: 10.4049/jimmunol.176.12.7412.
5
Tissue-specific Role of CXCR1 Expressing Immune Cells and Their Relationships with Human Disease.表达CXCR1的免疫细胞的组织特异性作用及其与人类疾病的关系。
Immune Netw. 2018 Jan 25;18(1):e5. doi: 10.4110/in.2018.18.e5. eCollection 2018 Feb.
6
Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes. fractalkine 诱导 CX3CR1 表达的单核细胞的血管生成潜能。
J Leukoc Biol. 2018 Jan;103(1):53-66. doi: 10.1189/jlb.1A0117-002RR. Epub 2017 Dec 28.
7
Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.腹主动脉瘤疾病中趋化因子/CX3CL1 及趋化因子受体(CX3CR1)表达的特征分析
Eur J Vasc Endovasc Surg. 2008 Jul;36(1):20-7. doi: 10.1016/j.ejvs.2008.01.014. Epub 2008 Mar 4.
8
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.增强 CX3CR1 阳性基因修饰人 T 细胞向 Fractalkine/CX3CL1 表达肿瘤的募集:趋化因子梯度的重要性。
J Immunother Cancer. 2016 Apr 19;4:21. doi: 10.1186/s40425-016-0125-1. eCollection 2016.
9
A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system.一种穿孔素/颗粒酶阳性的骨髓增生异常综合征衍生的T细胞系K2-MDS,通过趋化因子-CX3CR1系统诱导CD34+细胞凋亡。
Clin Immunol. 2004 Oct;113(1):109-16. doi: 10.1016/j.clim.2004.05.005.
10
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).人类动脉粥样硬化斑块中的平滑肌细胞表达趋化因子受体CX3CR1,并对CX3C趋化因子趋化素(CX3CL1)产生趋化作用。
Circulation. 2003 Nov 18;108(20):2498-504. doi: 10.1161/01.CIR.0000097119.57756.EF. Epub 2003 Oct 27.

引用本文的文献

1
Integrin-Mediated Exosomal Homing to Organs.整合素介导的外泌体归巢到器官中。
Methods Mol Biol. 2023;2668:145-158. doi: 10.1007/978-1-0716-3203-1_12.
2
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy.癌症外泌体与自然杀伤细胞功能障碍:生物学作用、临床意义及免疫治疗相关性
Mol Cancer. 2022 Jan 14;21(1):15. doi: 10.1186/s12943-021-01492-7.

本文引用的文献

1
C-C chemokine receptor type 2-overexpressing exosomes alleviated experimental post-stroke cognitive impairment by enhancing microglia/macrophage M2 polarization.过表达C-C趋化因子受体2的外泌体通过增强小胶质细胞/巨噬细胞M2极化减轻实验性中风后认知障碍。
World J Stem Cells. 2020 Feb 26;12(2):152-167. doi: 10.4252/wjsc.v12.i2.152.
2
CX3CL1 Signaling in the Tumor Microenvironment.CX3CL1 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2020;1231:1-12. doi: 10.1007/978-3-030-36667-4_1.
3
RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis.
RAMP3 决定了趋化因子受体-3 的非典型快速再循环,从而指导血管生成。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24093-24099. doi: 10.1073/pnas.1905561116. Epub 2019 Nov 11.
4
Talin-2 regulates integrin functions in exosomes.塔林-2 调节外泌体中整合素的功能。
Biochem Biophys Res Commun. 2019 May 7;512(3):429-434. doi: 10.1016/j.bbrc.2019.03.027. Epub 2019 Mar 14.
5
Exosomal regulation of lymphocyte homing to the gut.外泌体对淋巴细胞归巢至肠道的调节作用。
Blood Adv. 2019 Jan 8;3(1):1-11. doi: 10.1182/bloodadvances.2018024877.
6
Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients.鉴定趋化因子(CX3CL1)在肥胖相关癌症患者大网膜中记忆性 CD8 T 细胞积聚中的新作用。
Front Immunol. 2018 Aug 13;9:1867. doi: 10.3389/fimmu.2018.01867. eCollection 2018.
7
Lymphatic exosomes promote dendritic cell migration along guidance cues.淋巴 exosomes 促进树突状细胞沿引导线索迁移。
J Cell Biol. 2018 Jun 4;217(6):2205-2221. doi: 10.1083/jcb.201612051. Epub 2018 Apr 12.
8
The chemokine receptor CCR1 is identified in mast cell-derived exosomes.趋化因子受体CCR1在肥大细胞衍生的外泌体中被鉴定出来。
Am J Transl Res. 2018 Feb 15;10(2):352-367. eCollection 2018.
9
CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.CX3CR1/CX3CL1 轴介导有特发性深静脉血栓形成史的年轻患者血小板-白细胞黏附于动脉内皮。
Thromb Haemost. 2018 Mar;118(3):562-571. doi: 10.1055/s-0038-1629897. Epub 2018 Feb 12.
10
Current knowledge on exosome biogenesis and release.外泌体生物发生和释放的最新知识。
Cell Mol Life Sci. 2018 Jan;75(2):193-208. doi: 10.1007/s00018-017-2595-9. Epub 2017 Jul 21.